August 15th, 2013
Fuster to Succeed DeMaria as Editor of JACC
Larry Husten, PHD
The American College of Cardiology (ACC) has announced that Valentin Fuster will be the next editor-in-chief of the Journal of the American College of Cardiology (JACC). Fuster will succeed the current editor, Anthony DeMaria, beginning in 2014. “JACC has long been committed to bringing the newest and most innovative research to cardiovascular professionals, and Dr. Fuster brings […]
August 14th, 2013
Advanced Lipoprotein Analysis: Time for Widespread Implementation?
Behnood Bikdeli, M.D.
Will advanced lipoprotein analysis add real value to patients’ lives?
August 13th, 2013
Observational Study Lends Support to CRT Guidelines
Larry Husten, PHD
A large observational study published in JAMA suggests that patients with left bundle-branch block (LBBB) and longer QRS duration derive the most benefit from a cardiac resynchronization therapy defibrillator (CRT-D). The findings appear to support current, but often criticized, guidelines from the American College of Cardiology, American Heart Association, and the Heart Rhythm Society, in which a class I […]
August 12th, 2013
Selections from Richard Lehman’s Literature Review: August 12th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include BP targeting in patients with recent lacunar stroke, intermittent pneumatic compression for reducing DVT risk in patients who’ve had a stroke, and more.
August 11th, 2013
Radiation Exposure in the Cath Lab: A Radioactive Topic?
Reza Fazel, MD, MSc
How aware are you of the risks of radiation exposure from fluoroscopic procedures?
August 9th, 2013
The Guidelines are Dead. Long Live the Guidelines.
Larry Husten, PHD
Following the recent surprising announcement that the National Heart, Lung, and Blood Institute would no longer issue guidelines, leaders of the American Heart Association (AHA) and the American College of Cardiology (ACC) have now announced that are “officially assuming the joint governance, management and public distribution” of the enormously influential cardiovascular prevention guidelines, including the much-delayed and much-anticipated hypertension […]
August 7th, 2013
FDA Panel Recommends Approval of New Pulmonary Hypertension Drug
Larry Husten, PHD
The FDA’s Cardiovascular and Renal Drugs Advisory Committee recommended approval for Bayer’s new pulmonary hypertension drug, riociguat. The committee voted 11-0 in favor of approving the drug for two forms of pulmonary hypertension: pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTPH). Bayer proposed an initial dose of 1 mg three times daily and a maximum dose of […]
August 6th, 2013
George W. Bush Gets Stent After Annual Examination
Larry Husten, PHD
Former U.S. President George W. Bush received a stent today at Texas Health Presbyterian Hospital. Here is the statement from Bush’s office: During President George W. Bush’s annual physical examination at the Cooper Clinic in Dallas yesterday, a blockage was discovered in an artery in his heart. At the recommendation of his doctors, President Bush agreed to have a […]
August 5th, 2013
Putting the 2013 Heart Failure Guidelines Into Practice
Clyde Yancy, MD, Harlan M. Krumholz, MD, SM and John Ryan, MD
CardioExchange’s Harlan Krumholz and John Ryan interview Clyde W. Yancy, lead member of the ACCF/AHA task force that wrote the 2013 guidelines for management of heart failure. Krumholz and Ryan: What is the biggest challenge to implementing the heart failure guidelines for every patient with heart failure? Yancy: The biggest challenge is no longer in […]
August 5th, 2013
Poll: What Would You Recommend?
Richard A. Lange, MD, MBA
Take the poll: What would you recommend for a patient who is about to undergo CABG for multivessel CAD and is found to have severe carotid stenosis?